NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

The "Market" is supposedly forward looking but also wears blinders. In 1999 Gilead was doubted as "everyone knew" can not treat viruses with drugs. GILD traded $8-10 ($1.60-$2) split adjusted.
Arrowhead languished for years sub $2 and shot up to $70 plus in 18 months in 2018 even before any approvals as the "Market" finally 'Got It" that they had a new technology of gene silencing that the "Market" previously did not understand.
The big gains in NWBO will be when the Market Gets It. That will likely be on TLD and Journal. Actual approval of DcVax-L might be anticlimactic, however further trials should add further catalysts for the stock price.
In any development pre revenue investment there are dangers in being too early and being too late. Too early is over and might be the reason some former investors remain so bitter. It is not too late and as you say the inflection point can come as early as next week. Immediate 5x to 10x is not out of the question and a 25x in just a few weeks is possible as what happened to Avavex Life Sciences just about a year ago following the same trajectory of a few years earlier in Arrowhead.
Next week or a few weeks. NWBO is pregnant we just can not tell exactly when she will give birth to DCVax-L because we do not know the gestation period. Only a fool would think it will be a still birth due to the careful prenatal care this has received and the accelerating preparations that have been made by those that are privy to the sonograms.
BTW the Lindas' baby is a Girl as she is likely to give birth many more beautiful and elegant offspring for other cancers.